| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955179 | Chest | 2013 | 6 Pages |
Abstract
Pulmonary Langerhans cell histiocytosis appears to be a clonal proliferation that may or may not have BRAF V600E mutations. For those with BRAF V600E mutations, new targeted therapies, such as vemurafenib, may be used in progressive cases.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Samuel A. MD, FCCP, Sanja MD, PhD, Yuri E. MD, PhD, Marina MD,